CTSO · Cytosorbents Corp
United States · RS rating 99 · As of 2026-11-03
| Price | 4.54 USD |
|---|---|
| 1-day change | +10.2% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 89 / 99 / 98 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 41 / 71 / 57 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +11.1% |
| Sales growth Q/Q | -2.6% |
| Distance from 52-week high | +33.7% |
| Market cap (USD) | $40.7M |